Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T1566 |
Aripiprazole
阿立哌唑,OPC-14597 |
5-HT Receptor | GPCR/G Protein; Neuroscience |
Aripiprazole (OPC-14597) 是血清素受体 5-HT1A 和多巴胺 D2 受体的部分激动剂,还用作突触后拮抗剂和血清素受体 5-HT2A 的拮抗剂。 | |||
T14319 |
Aripiprazole Lauroxil
|
Dopamine Receptor; 5-HT Receptor | GPCR/G Protein; Neuroscience |
Aripiprazole lauroxil 是一种长效注射剂 (LAI) 的抗精神病药物,是阿立哌唑的 N-酰氧基甲基前药形式。它能够被体内酯酶裂解为 N-羟甲基阿立哌唑(月桂酸),再裂解为阿立哌唑,无毒性。 | |||
T30131 |
Aripiprazole cavoxil
|
||
Aripiprazole cavoxil is used in Treatment of Schizophrenia, Bipolar Disorder, and Clinical Depression. | |||
T36664 |
Dehydro Aripiprazole (hydrochloride)
|
||
Dehydro aripiprazole is the primary, active metabolite of aripiprazole, an atypical antipsychotic. The metabolite is produced from the parent compound by the actions of cytochrome P450 (CYP) isoforms CYP3A4 and CYP2D6. Dehydro aripiprazole has similar pharmacological properties to aripiprazole. | |||
T10368 |
Aripiprazole (D8)
OPC-14597 D8 |
Others | Others |
Aripiprazole D8 (OPC-14597 D8) is the deuterium-labeled Aripiprazole. Aripiprazole is a human 5-HT1A receptor partial agonist (Ki: 4.2 nM). | |||
T62982 |
Aripiprazole monohydrate
|
||
Aripiprazole (OPC-14597) monohydrate 是一种非典型抗精神病药,是一种有效的、高亲和力的多巴胺 D2 受体部分激动剂。Aripiprazole monohydrate 是 5-HT2B 和 5-HT2A 受体的反向激动剂,对 5-HT1A、5-HT2C、D3 和 D4 受体表现出部分激动剂作用。Aripiprazole monohydrate 能够用于研究精神分裂症和 COVID19。 | |||
T10989 |
Dehydroaripiprazole
OPC-14857,DM-14857 |
5-HT Receptor | GPCR/G Protein; Neuroscience |
Dehydroaripiprazole (DM-14857) 是 Aripiprazole 的活性代谢产物,具有抗精神病活性。Aripiprazole 是也一种抗精神病药。 | |||
T29064 |
UNC9975
UNC-9975 |
||
UNC9975 is an analog of aripiprazole and a β-arrestin-biased D2R agonist. |